What metrics would you use to evaluate Schrödinger's FEP+ free energy calculation technology?

Introduction

Evaluating Schrödinger's FEP+ free energy calculation technology requires a comprehensive approach to product success metrics. This advanced computational chemistry tool plays a crucial role in drug discovery and development, demanding careful consideration of its performance, accuracy, and impact on the pharmaceutical research process. I'll follow a structured framework covering core metrics, supporting indicators, and risk factors while considering all key stakeholders.

Step 1

Product Context

Schrödinger's FEP+ (Free Energy Perturbation) technology is a sophisticated computational method used in drug discovery to predict binding affinities between small molecules and protein targets. It's a critical tool for pharmaceutical companies and research institutions aiming to accelerate the drug development process and reduce costs associated with experimental testing.

Key stakeholders include:

1. Pharmaceutical companies: Seeking to optimize lead compounds and reduce time-to-market
2. Research scientists: Using FEP+ to guide their molecular design decisions
3. Computational chemists: Relying on FEP+ for accurate predictions
4. Schrödinger: Aiming to maintain market leadership in computational chemistry tools

User flow typically involves:

1. Preparing molecular systems for calculation
2. Running FEP+ simulations
3. Analyzing results and making decisions on compound optimization

FEP+ fits into Schrödinger's broader strategy of providing cutting-edge computational tools for drug discovery, complementing their other offerings like Glide for docking and Prime for protein modeling.

Compared to competitors like OpenEye and ChemAxon, Schrödinger's FEP+ is known for its high accuracy and integration with other tools in their suite. However, it faces challenges in computational cost and ease of use.

In terms of product lifecycle, FEP+ is in the growth stage, with increasing adoption in the pharmaceutical industry but still room for expansion and improvement.

Software-specific context:

• Platform: Runs on high-performance computing clusters
• Integration: Connects with other Schrödinger tools and external databases
• Deployment: Both on-premises and cloud-based options available